메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Luxury Jeweler, Chow Sang Sang, Selects Nuvei to Power Online Payments and Accelerate Global Expansion

Iconic brand joins growing roster of Nuvei merchants scaling globally from Hong Kong MONTREAL, Aug. 6, 2025 -- Nuvei today announced that Chow Sang Sang Holdings International Limited (HKEX: 116), one of the most iconic jewelers in Greater China, has selected its global payments platform to drive the next phase of its international growth, staring with expansion into North America. Nuvei recently received a Money Services Operator (MSO) license in Hong Kong, enabling the company to offer local acquiring and settlement in one of Asia's most strategically important market
- 황정호 기자
- 2025-08-06 20:30
Xinhua Silk Road: British online content creator impressed by achievements of Chinese dairy giant Mengniu in desertification fight

BEIJING, Aug. 6, 2025 -- British online content creator Jack Forsdike witnessed achievements of Chinese dairy giant Mengniu in combating desertification during his recent visit to the Ulan Buh Desert in north China's Inner Mongolia Autonomous Region. To fight desertification, Mengniu has transformed over 200 square kilometers of desert into green pasture in recent years, planting more than 97 million trees. The project demonstrates how Chinese enterprises make ESG efforts to better the environment around them. In July, Jack toured the green pasture, which now pro
- 황정호 기자
- 2025-08-06 20:28
Shamal Holding Unveils Naïa Island Dubai

[ 메디채널 황정호 기자 ] A Private Estate Setting New Standards in Ultra-Luxury Living DUBAI, UAE, Aug. 6, 2025 -- Shamal Holding, the Dubai-based diversified investment firm, today unveils Naïa Island Dubai - a landmark private estate set to redefine ultra-luxury living in the region. At its heart, the island will host the region's first Cheval Blanc maison, a defining moment for hospitality in the region. The maison will feature an intimate collection of suites and private villas, designed in Cheval Blanc's distinctive style: contemporary, serene, and emotional
- 황정호 기자
- 2025-08-06 20:10
ACEN earns top ESG recognitions from FTSE4Good Index and MSCI

MAKATI CITY, Philippines , Aug. 6, 2025 -- ACEN, the listed renewable energy platform of the Ayala Group, continues to demonstrate ESG leadership, securing recognition from two of the world's leading Environmental, Social and Governance (ESG) rating agencies: FTSE Russell and MSCI. These recognitions reflect ACEN's ongoing commitment to embed sustainability at the heart of its strategy, anchored on environmental stewardship, social responsibility, and sound corporate governance. ACEN has once again retained its place in the FTSE4Good Index Series for the third yea
- 황정호 기자
- 2025-08-06 20:09
U Power Partners with Chia Tai and ICBC Thai to Advance Use of Intelligent and Battery-Swapping Compatible Agricultural Drones in Thailand

[ 메디채널 황정호 기자 ] Accelerating the Digitalization and Smart Transformation of Thailand's Farming Sector SHANGHAI, Aug. 6, 2025 -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a provider of AI-powered solutions for next-generation energy grids and intelligent transportation systems, building on its proprietary UOTTATM electric vehicle (EV) battery-swapping technology, today announced that it has signed a Memorandum of Understanding ("MOU") with Chia Tai Co., Ltd. ("Chia Tai"), Thailand's leading innovative agricultural company and
- 황정호 기자
- 2025-08-06 20:00
FDA approves expanded indication for AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in cytokine release syndrome (CRS)

Approval of AVTOZMA® (tocilizumab-anoh) intravenous infusion expands label to include treatment of adults and pediatric patients aged 2 years and older with cytokine release syndrome (CRS) [1] AVTOMZA received FDA approval in January 2025, for multiple inflammatory indications including rheumatoid arthritis (RA), giant cell arteritis (GCA), polyarticular juvenile idiopathic arthritis (pJIA), systemic juvenile idiopathic arthritis (sJIA) and coronavirus disease (COVID-19) in IV formulation [1] INCHEON, South Korea, Aug. 6, 2025 -- Celltrion, Inc. today announced that
- 김갑성 기자
- 2025-08-06 20:00
Continuity Biosciences Appoints Josephine Torrente and Joseph DeSimone, PhD to Board of Directors

BRADENTON, Fla., Aug. 6, 2025 -- Continuity Biosciences, a company pioneering next-generation combination product drug delivery, today announced the appointment of two highly distinguished leaders to its Board of Directors: Josephine M. Torrente, Director at Hyman, Phelps & McNamara, P.C., and Dr. Joseph M. DeSimone, serial entrepreneur and professor at Stanford University. These appointments mark a significant step forward in Continuity's mission to advance transformative drug delivery technologies, supported by world-class regulatory expertise and materials science innovation.&n
- 김갑성 기자
- 2025-08-06 20:00
HR Path Strengthens Global Presence with Strategic Acquisition of PredictiveHR

PARIS, Aug. 6, 2025 -- HR Path, a global leader in HR consulting and HRIS solutions, is proud to announce its strategic acquisition of PredictiveHR, a U.S.-based company renowned for its deep expertise in HRIS advisory and implementation services, with a strong specialization in UKG solutions. With a presence in 28 countries and a team of over 2,500 professionals, HR Path is a trusted partner for businesses navigating the complexities of Human Resources. Specializing in advisory, implementation, and operational services, HR Path delivers cutting-edge solutions designed to enhan
- 황정호 기자
- 2025-08-06 20:00
HR Path、PredictiveHRの戦略的買収によりグローバル展開を強化

パリ, 2025年8月6日 --HRコンサルティングおよび人事情報システム（HRIS）ソリューションの世界的リーダーであるHR Pathは、米国に拠点を置き、HRISに関するコンサルティングおよび導入サービスにおける豊富な専門知識を持ち、特にUKGソリューションに強みを持つPredictiveHRを戦略的に買収したことを発表いたします。 HR Pathは、28か国に展開し、2,500人以上の専門家を擁する企業として、人事の複雑な課題に取り組むビジネスの信頼できるパートナーです。HR Pathは、アドバイザリー、実行、および運用サービスを専門とし、効率を向上させ成長を促進するために設計された最先端のソリューションを提供しています。2001年の設立以来、同社は世界の人事関連業務を変革するという使命を堅持しています。 2016年以降、PredictiveHRはUKGやPaylocityといった人事テクノロジープラットフォームを活用する企業にとって、信頼できるプロフェッショナルサービスパートナーとしての地位を築いてきました。100年以上にわたるコンサルティング経験を結集した当社は、導入、最適化、運用開始後のサポートに特化しており、システムの定着を促進し、業務を効率化し、測定可能な成果をもたらすサービスを提供しています。PredictiveHRは
- 황정호 기자
- 2025-08-06 20:00
컨티뉴이티 바이오사이언스, 이사회에 조세핀 토렌테, 조지프 디시몬 영입

브레이든턴, 플로리다, 2025년 8월 6일 -- 차세대 복합 약물 전달 분야의 선도 기업인 컨티뉴이티 바이오사이언스(Continuity Biosciences)가 이사회에 두 명의 저명한 인사를 영입했다고 발표했다. 새로 합류한 인사는 조세핀 M. 토렌테(Josephine M. Torrente) 하이먼, 펠프스 & 맥나마라(Hyman, Phelps & McNamara, P.C.) 이사와 조지프 M. 디시몬(Dr. Joseph M. DeSimone) 스탠퍼드대학교 교수이자 연쇄 창업가다. 이번 선임은 세계적인 규제 전문성과 재료과학 혁신을 바탕으로 혁신적인 약물 전달 기술을 발전시키려는 콘티뉴이티의 사명에 있어 중요한 진전으로 평가된다. 조세핀 M. 토렌테 현직: 미국 최대 규모의 FDA 규제 전문 법률 회사인 하이먼, 펠프스 & 맥나마라(Hyman, Phelps & McNamara, P.C.) 이사 경력: 30년 이상 제약 및 바이오 기업을 대상으로 FDA 규제 전략, 제품 개발, 전주기 관리 등에 대해 자문 전략적 기여: 토렌테 이사의 깊이 있는 규제 통찰력을 통해 회사가
- 김갑성 기자
- 2025-08-06 20:00

이전

91 92 93 94 95 96 97 98 99 100

많이 본 기사

최근기사

2025-09-06_SAT

2025-09-05_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 06일 06시 40분